New study sheds light on vision loss in rare genetic brain disorders
NCT ID NCT07019558
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how spinocerebellar ataxia (SCA) affects the eyes and vision. Researchers will examine 60 adults with SCA types 1, 2, 3, or 27B, including those with early symptoms and those who are not yet symptomatic. The goal is to measure vision changes and eye damage using tests like eye exams and scans, helping to better understand these rare neurological diseases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINOCEREBELLAR ATAXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Montpellier - Hôpital Gui de Chauliac
RECRUITINGMontpellier, Hérault, 34000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can targeted brain zaps ease movement problems in a rare ataxia?
- Can we predict how genetic ataxias progress?
- Scientists decode gait signatures to spot brain diseases
- SCA27B study aims to map disease progression in 300 participants
- Could stem cells help people with spinocerebellar ataxia?
- New hope for SCA patients: expanded access to investigational drug troriluzole